Back to Journals » Vascular Health and Risk Management » Volume 6
Original Research
Levosimendan neither improves nor worsens mortality in patients with cardiogenic shock due to ST-elevation myocardial infarction
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
10,749 | Dovepress* | 10,749+ | 3,266 | 14,015 | |
Totals | 10,749 | 3,266 | 14,015 | ||
*Since 26 August 2010 +Since July 2016 |
View citations on Google Scholar